AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33468118 — intervention group
Group type: EXPERIMENTAL
Intervention: Argumentative writing (AW)
Number of subjects: 139
Study 33468118 — intervention group
Group type: COMPARATOR
Intervention: Self-study (SS)
Number of subjects: 139
Study 36450458 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin + Ezetimibe (S+E)
Number of subjects: 79
Study 36450458 — intervention group
Group type: COMPARATOR
Intervention: Statin (S)
Number of subjects: 79
Study 33656484 — intervention group
Group type: EXPERIMENTAL
Intervention: Compensatory Cognitive Training (CCT)
Number of subjects: 0
Study 33631965 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry oxygen
Number of subjects: 51
Study 33631965 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry air
Number of subjects: 51
Study 33631965 — intervention group
Group type: EXPERIMENTAL
Intervention: Humidified oxygen
Number of subjects: 51
Study 33631965 — intervention group
Group type: COMPARATOR
Intervention: Humidified air
Number of subjects: 51
Study 35445840 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTH
Number of subjects: 38
Study 35445840 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone
Number of subjects: 38
Study 34477823 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy
Number of subjects: 537
Study 34477823 — intervention group
Group type: COMPARATOR
Intervention: Avoid antiplatelet therapy (Control)
Number of subjects: 537
Study 34799682 — intervention group
Group type: EXPERIMENTAL
Intervention: D-Cycloserine (DCS) 50 mg
Number of subjects: 90
Study 34799682 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC) 25 mg
Number of subjects: 90
Study 34799682 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 34604426 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellar tendon autograft (PT)
Number of subjects: 62
Study 34604426 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamstring tendon autograft (HT)
Number of subjects: 62
Study 34604426 — intervention group
Group type: COMPARATOR
Intervention: Both PT and HT groups
Number of subjects: 62
Study 35486962 — intervention group
Group type: EXPERIMENTAL
Intervention: One-to-one midwifery care
Number of subjects: 7103
Study 33599684 — intervention group
Group type: EXPERIMENTAL
Intervention: 3DP swab
Number of subjects: 89
Study 34856181 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin (200 μg/kg) plus Albendazole (400 mg)
Number of subjects: 733
Study 34856181 — intervention group
Group type: COMPARATOR
Intervention: Albendazole (400 mg) plus Placebo
Number of subjects: 733
Study 33435897 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezocision-assisted orthodontics
Number of subjects: 23
Study 33435897 — intervention group
Group type: COMPARATOR
Intervention: Control (only extraction)
Number of subjects: 23
Study 36242052 — intervention group
Group type: EXPERIMENTAL
Intervention: Photography tele‐transmission by ambulance staff
Number of subjects: 165
Study 36242052 — intervention group
Group type: COMPARATOR
Intervention: Control group (no photography tele‐transmission)
Number of subjects: 165
Study 34127635 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning to ride a bicycle
Number of subjects: 62
Study 34127635 — intervention group
Group type: COMPARATOR
Intervention: Stationary cycling
Number of subjects: 62
Study 34127635 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study 34532895 — intervention group
Group type: EXPERIMENTAL
Intervention: BUP-NX
Number of subjects: 400
Study 34532895 — intervention group
Group type: COMPARATOR
Intervention: XR-NTX
Number of subjects: 400
Study 33301254 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced recovery program after VATS surgery
Number of subjects: 235
Study 33301254 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated recovery protocol after open surgery
Number of subjects: 235
Study 33301254 — intervention group
Group type: COMPARATOR
Intervention: Traditional management after open surgery
Number of subjects: 235
Study 33301254 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced recovery program after open surgery
Number of subjects: 235
Study 33301254 — intervention group
Group type: EXPERIMENTAL
Intervention: VATS operations
Number of subjects: 235
Study 33301254 — intervention group
Group type: COMPARATOR
Intervention: Traditional management
Number of subjects: 235
Study 35395204 — intervention group
Group type: EXPERIMENTAL
Intervention: gameChange VR therapy plus usual care
Number of subjects: 346
Study 35395204 — intervention group
Group type: COMPARATOR
Intervention: usual care alone
Number of subjects: 346
Study 34127100 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of Transcranial Magnetic Stimulation (rTMS) with Ketamine (CTK)
Number of subjects: 28
Study 32460811 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of psychosocial distress in doctor-patient conversation
Number of subjects: 616
Study 32460811 — intervention group
Group type: COMPARATOR
Intervention: Assessment of psychosocial distress via questionnaire (control, standard of care)
Number of subjects: 616
Study 32460811 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctor-patient consultation
Number of subjects: 616
Study 34774396 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 159
Study 34774396 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX) continued group
Number of subjects: 159
Study 34774396 — intervention group
Group type: COMPARATOR
Intervention: Daily buprenorphine-naloxone (BP-NLX)
Number of subjects: 159
Study 34774396 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (XR-NTX and BP-NLX)
Number of subjects: 159
Study 34774396 — intervention group
Group type: EXPERIMENTAL
Intervention: High LS group
Number of subjects: 159
Study 34774396 — intervention group
Group type: EXPERIMENTAL
Intervention: Illicit opioid use
Number of subjects: 159
Study 34096500 — intervention group
Group type: COMPARATOR
Intervention: Enteral feeding during therapeutic hypothermia
Number of subjects: 6030
Study 34096500 — intervention group
Group type: COMPARATOR
Intervention: Parenteral nutrition during therapeutic hypothermia
Number of subjects: 6030
Study 35650663 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped Classroom (FC)
Number of subjects: 40
Study 35650663 — intervention group
Group type: COMPARATOR
Intervention: Live Demonstration (LD)
Number of subjects: 40
Study 34512511 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment (target SBP 130-140 mmHg)
Number of subjects: 2196
Study 34512511 — intervention group
Group type: COMPARATOR
Intervention: Guideline-recommended treatment (SBP <180 mmHg)
Number of subjects: 2196
Study 35511372 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled outpatient follow-up on demand
Number of subjects: 0
Study 35511372 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 33298126 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped-care approach BETTER CARE
Number of subjects: 540
Study 33298126 — intervention group
Group type: COMPARATOR
Intervention: Usual care+
Number of subjects: 540
Study 35979609 — intervention group
Group type: EXPERIMENTAL
Intervention: 900 mg UDCA for 6 months
Number of subjects: 0
Study 35979609 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 0
Study 32673082 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage alone
Number of subjects: 42
Study 32673082 — intervention group
Group type: COMPARATOR
Intervention: Massage plus acupuncture
Number of subjects: 42
Study 35984934 — intervention group
Group type: EXPERIMENTAL
Intervention: THR device
Number of subjects: 16
Study 35984934 — intervention group
Group type: EXPERIMENTAL
Intervention: FTCR device
Number of subjects: 16
Study 33976352 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon nanoparticle suspension
Number of subjects: 160
Study 33976352 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study 36307193 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure control (systolic blood pressure <120 mm Hg)
Number of subjects: 14094
Study 36307193 — intervention group
Group type: COMPARATOR
Intervention: Standard systolic blood pressure control (systolic blood pressure <140 mm Hg)
Number of subjects: 14094
Study 36307193 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure control
Number of subjects: 14094
Study 32665041 — intervention group
Group type: EXPERIMENTAL
Intervention: Sudarshan Kriya Yoga (SKY)
Number of subjects: 60
Study 32665041 — intervention group
Group type: COMPARATOR
Intervention: Health Enhancement Program (HEP)
Number of subjects: 60
Study 33601706 — intervention group
Group type: EXPERIMENTAL
Intervention: Next-intended antidepressant (AD) treatment with predicted moderate gene-drug interaction potential
Number of subjects: 1149
Study 33601706 — intervention group
Group type: EXPERIMENTAL
Intervention: Next-intended antidepressant (AD) treatment with predicted clinically significant gene-drug interaction potential
Number of subjects: 1149
Study 33601706 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous treatment with an antidepressant (AD) in the past two years
Number of subjects: 1149
Study 33028082 — intervention group
Group type: EXPERIMENTAL
Intervention: MultiPoint pacing with wide anatomic separation (MPP‐AS)
Number of subjects: 506
Study 33028082 — intervention group
Group type: COMPARATOR
Intervention: Biventricular single-site pacing
Number of subjects: 506
Study 35487576 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO + BHB-ME (20 ± 2 g CHO and 590 mg/kg body mass β-hydroxybutyrate monoester)
Number of subjects: 9
Study 35487576 — intervention group
Group type: COMPARATOR
Intervention: CHO (90 ± 9 g carbohydrate)
Number of subjects: 9
Study 35487576 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO + BHB-ME
Number of subjects: 9
Study 33576146 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week group mindfulness-based cognitive behavioral intervention via videoconference
Number of subjects: 47
Study 34870387 — intervention group
Group type: EXPERIMENTAL
Intervention: Accommodating variable-resistance exercise (AVr-Ex) program, 3 sessions/week over 8 weeks, in addition to usual physical therapy
Number of subjects: 36
Study 34187220 — intervention group
Group type: EXPERIMENTAL
Intervention: Accuracy incentives to estimate prognosis
Number of subjects: 200
Study 34187220 — intervention group
Group type: EXPERIMENTAL
Intervention: Framing treatment benefits in terms of loss (mortality)
Number of subjects: 200
Study 32249696 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation intervention (90-day training with self-practice)
Number of subjects: 136
Study 32249696 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 136
Study 35700149 — intervention group
Group type: EXPERIMENTAL
Intervention: Avocado (AV)
Number of subjects: 93
Study 35700149 — intervention group
Group type: COMPARATOR
Intervention: Control food (C; low fat, low fiber, energy matched)
Number of subjects: 93
Study 33181415 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted temperature management (TTM) at 33 °C for either 24 or 48 hours
Number of subjects: 355
Study 32143733 — intervention group
Group type: EXPERIMENTAL
Intervention: Witnessed oral informed consent (IC) prior to randomization and written IC after percutaneous coronary intervention for ST-segment elevation myocardial infarction patients.
Number of subjects: 414
Study 32143733 — intervention group
Group type: EXPERIMENTAL
Intervention: Witnessed oral informed consent (IC) prior to randomization and written IC before angiography for non-ST-segment elevation myocardial infarction patients.
Number of subjects: 414
Study 32143733 — intervention group
Group type: EXPERIMENTAL
Intervention: Witnessed oral informed consent (IC) process.
Number of subjects: 414
Study 35394456 — intervention group
Group type: EXPERIMENTAL
Intervention: NCX 470 0.042%
Number of subjects: 433
Study 35394456 — intervention group
Group type: EXPERIMENTAL
Intervention: NCX 470 0.065%
Number of subjects: 433
Study 35394456 — intervention group
Group type: EXPERIMENTAL
Intervention: NCX 470 0.021%
Number of subjects: 433
Study 35394456 — intervention group
Group type: COMPARATOR
Intervention: Latanoprost 0.005%
Number of subjects: 433
Study 33428608 — intervention group
Group type: EXPERIMENTAL
Intervention: Lightwand-guided insertion technique
Number of subjects: 54
Study 33428608 — intervention group
Group type: COMPARATOR
Intervention: Standard digital manipulation technique
Number of subjects: 54
Study 32755460 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised learning algorithms for classifying basal cell carcinoma
Number of subjects: 43794
Study 32755460 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised learning algorithms for classifying squamous cell carcinoma
Number of subjects: 43794
Study 32755460 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised learning algorithms for total counts of specific diagnoses
Number of subjects: 43794
Study 32755460 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised learning algorithms for classifications of keratoacanthoma and intraepidermal carcinoma
Number of subjects: 43794
Study 36328372 — intervention group
Group type: EXPERIMENTAL
Intervention: Ornidazole 1 g orally 12 hours before surgery
Number of subjects: 926
Study 36328372 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 926
Study 35718979 — intervention group
Group type: EXPERIMENTAL
Intervention: Italian group (10 patients)
Number of subjects: 14
Study 35718979 — intervention group
Group type: COMPARATOR
Intervention: Czech group (4 patients)
Number of subjects: 14
Study 33799055 — intervention group
Group type: EXPERIMENTAL
Intervention: Chatbot intervention (Todaki)
Number of subjects: 46
Study 33799055 — intervention group
Group type: COMPARATOR
Intervention: Information-only control (book on managing attention deficit symptoms)
Number of subjects: 46
Study 35766258 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including bedside delivery of P2Y12 inhibitor, education, automated reminder calls, and outreach for refill delays.
Number of subjects: 1377
Study 35766258 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Number of subjects: 1377
Study 35766258 — intervention group
Group type: COMPARATOR
Intervention: Preintervention control group
Number of subjects: 1377
Study 35766258 — intervention group
Group type: COMPARATOR
Intervention: Postintervention control group
Number of subjects: 1377
Study 35766258 — intervention group
Group type: COMPARATOR
Intervention: Concurrent control group
Number of subjects: 1377
Study 34665845 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar support with built-in massager system
Number of subjects: 24
Study 34665845 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lumbar support)
Number of subjects: 24
Study 32338063 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg DBPR108
Number of subjects: 271
Study 32338063 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg DBPR108
Number of subjects: 271
Study 32338063 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg DBPR108
Number of subjects: 271
Study 32338063 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 271
Study 34126778 — intervention group
Group type: EXPERIMENTAL
Intervention: Getting To Outcomes (GTO) implementation support strategy with RDAD training
Number of subjects: 0
Study 34126778 — intervention group
Group type: COMPARATOR
Intervention: Usual implementation of RDAD without GTO training
Number of subjects: 0
Study 33404141 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentivised adherence and abstinence monitoring (I-AAM)
Number of subjects: 141
Study 33404141 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 141
Study 35488452 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy
Number of subjects: 1726
Study 35488452 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐Behavioral Therapy
Number of subjects: 1726
Study 35488452 — intervention group
Group type: EXPERIMENTAL
Intervention: Twelve‐Step Facilitation
Number of subjects: 1726
Study 35488452 — intervention group
Group type: COMPARATOR
Intervention: URICA (University of Rhode Island Change Assessment Scale)
Number of subjects: 1726
Study 613877316 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-stress condition
Number of subjects: 39
Study 613877316 — intervention group
Group type: COMPARATOR
Intervention: High-stress condition
Number of subjects: 39
Study 613877316 — intervention group
Group type: COMPARATOR
Intervention: High-stress condition (women)
Number of subjects: 39
Study 613877316 — intervention group
Group type: COMPARATOR
Intervention: High-stress condition (men)
Number of subjects: 39
Study 37290207 — intervention group
Group type: EXPERIMENTAL
Intervention: NEPA + no further DEX (DEX1)
Number of subjects: 107
Study 37290207 — intervention group
Group type: EXPERIMENTAL
Intervention: NEPA + oral low-dose DEX (4 mg) on days 2-3 (DEX3)
Number of subjects: 107
Study 37290207 — intervention group
Group type: EXPERIMENTAL
Intervention: NEPA + standard DEX (4 mg twice daily) on days 2-4 (DEX4)
Number of subjects: 107
Study 33896356 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg/2 mL pre-filled syringe (PFS)
Number of subjects: 214
Study 33896356 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study 33980778 — intervention group
Group type: EXPERIMENTAL
Intervention: Writing and reading aloud positive events
Number of subjects: 57
Study 33980778 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual work)
Number of subjects: 57
Study 33641430 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg/kg intravenous tranexamic acid (TXA) diluted in 100 ml normal saline (NS)
Number of subjects: 165
Study 33641430 — intervention group
Group type: COMPARATOR
Intervention: IV placebo 100 ml normal saline (NS)
Number of subjects: 165
Study 32520387 — intervention group
Group type: EXPERIMENTAL
Intervention: Long pulse-width Holmium-YAG laser lithotripsy
Number of subjects: 32
Study 32520387 — intervention group
Group type: COMPARATOR
Intervention: Short pulse-width Holmium-YAG laser lithotripsy
Number of subjects: 32
Study 34016120 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 9340
Study 34016120 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9340
Study 32124422 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal intervention including adapted tango, music therapy, social activities, cognitive intervention, and psycho-education for 6 months.
Number of subjects: 300
Study 32124422 — intervention group
Group type: COMPARATOR
Intervention: Psycho-education and advice on healthy lifestyle for 6 months (Control group).
Number of subjects: 300
Study 33159177 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended C‐ILMP (EC‐ILMP)
Number of subjects: 100
Study 33159177 — intervention group
Group type: COMPARATOR
Intervention: Conventional internal limiting membrane peeling (C‐ILMP)
Number of subjects: 100
Study 32977202 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitspiration images
Number of subjects: 223
Study 32977202 — intervention group
Group type: EXPERIMENTAL
Intervention: Thinspiration images
Number of subjects: 223
Study 32977202 — intervention group
Group type: COMPARATOR
Intervention: Neutral images
Number of subjects: 223
Study 34142664 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (72% of patients, 126 of 174)
Number of subjects: 174
Study 34142664 — intervention group
Group type: COMPARATOR
Intervention: Casting (28% of patients, 48 of 174)
Number of subjects: 174
Study 34142664 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (when prioritizing ROM over pain reduction more than 80:20)
Number of subjects: 174
Study 34142664 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (when prioritizing grip strength over pain reduction more than 70:30)
Number of subjects: 174
Study 35527256 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical mask
Number of subjects: 216
Study 35527256 — intervention group
Group type: COMPARATOR
Intervention: Cloth mask
Number of subjects: 216
Study 32081238 — intervention group
Group type: EXPERIMENTAL
Intervention: Zilver PTX stent
Number of subjects: 186
Study 32081238 — intervention group
Group type: COMPARATOR
Intervention: Misago stent
Number of subjects: 186
Study 36794542 — intervention group
Group type: EXPERIMENTAL
Intervention: Regenerative limb salvage (rLS) using dehydrated human chorion amnion membrane (dHACM)
Number of subjects: 39
Study 36794542 — intervention group
Group type: COMPARATOR
Intervention: Flap-based limb salvage (fLS)
Number of subjects: 39
Study 33660033 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-infected individuals
Number of subjects: 300
Study 33660033 — intervention group
Group type: COMPARATOR
Intervention: HIV-uninfected individuals
Number of subjects: 300
Study 35141886 — intervention group
Group type: EXPERIMENTAL
Intervention: Early placement of hormonal IUD (LNG-IUS, Mirena®) within 48 hours after delivery
Number of subjects: 101
Study 35141886 — intervention group
Group type: COMPARATOR
Intervention: Standard placement of hormonal IUD (LNG-IUS, Mirena®) 6–8 weeks postpartum
Number of subjects: 101
Study 34496721 — intervention group
Group type: EXPERIMENTAL
Intervention: Traction-manipulation protocol
Number of subjects: 0
Study 34496721 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32487507 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 1-mg hydromorphone tablets or no hydromorphone if no opioids were required in hospital
Number of subjects: 40
Study 32487507 — intervention group
Group type: COMPARATOR
Intervention: 20 1-mg hydromorphone tablets (standard post-cesarean opioid prescription)
Number of subjects: 40
Study 35935409 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapered discontinuation of antipsychotic medication
Number of subjects: 29
Study 35935409 — intervention group
Group type: COMPARATOR
Intervention: Maintenance treatment with antipsychotic medication
Number of subjects: 29
Study 32016928 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA) - bolus dose of 10 mg/kg followed by 8 hours continuous infusion of 3 mg/kg/h
Number of subjects: 30
Study 32016928 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA)
Number of subjects: 30
Study 32016928 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 35102364 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric hop extract (500 mg, quick-release capsules)
Number of subjects: 19